To evaluate direct medical costs and their predictors in patients with refractory epilepsy enrolled into the SOPHIE study (Study of Outcomes of PHarmacoresistance In Epilepsy) in Italy.

A prospective study of direct medical costs in a large cohort of consecutively enrolled patients with refractory epilepsy in Italy

LUONI, CHIARA;GALIMBERTI, CARLO ANDREA;GATTI, GIULIANA;MAZZUCCHELLI, IOLANDA;ROSATI, ELEONORA;STRIANO, SALVATORE;PERUCCA, EMILIO
2015-01-01

Abstract

To evaluate direct medical costs and their predictors in patients with refractory epilepsy enrolled into the SOPHIE study (Study of Outcomes of PHarmacoresistance In Epilepsy) in Italy.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/1102292
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 23
  • ???jsp.display-item.citation.isi??? 19
social impact